45 min listen
Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
ratings:
Length:
61 minutes
Released:
Aug 22, 2023
Format:
Podcast episode
Description
Dr Hans Lee from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in New York, New York, discuss approved and novel bispecific antibodies and their current and potential roles in the treatment of multiple myeloma.
CME information and select publications here (https://researchtopractice.com/OncologyTodayPostASCO23/BreastCancer).
CME information and select publications here (https://researchtopractice.com/OncologyTodayPostASCO23/BreastCancer).
Released:
Aug 22, 2023
Format:
Podcast episode
Titles in the series (100)
Oncology Today with Dr Neil Love: Small Cell Lung Cancer Edition: For this special edition of Oncology Today, I met with Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York to discuss recently published and emerging research in the management of small cell lung cancer. by Oncology Today with Dr Neil Love